SCHEMBL21396874

SCHEMBL21396874

N#Cc1c(-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4)ccc32)cc(-c2ccc(-n3c4ccccc4c4ccncc43)cc2)cc1-n1c2ccc(-c3ccccc3)cc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 3/20 0.39
KDM4E B2RXH2 2/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CDK4 P11802 1/20 0.34
CDK6 Q00534 1/20 0.34
DHODH Q02127 1/20 0.33
PDE10A Q9Y233 1/20 0.33
NPY5R Q15761 1/20 0.33
MEN1 O00255 1/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
TSPO P30536 1/20 0.32
HDAC4 P56524 1/20 0.32
CYP11B1 P15538 1/20 0.32
MAOA P21397 1/20 0.32
SQOR Q9Y6N5 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396875 0.98 CYP11B2 (0.36) CYP11B2KDM4ECDK4CDK6DHODH
SCHEMBL21396880 0.94 CYP11B2 (0.38) CYP11B2KDM4EATML3MBTL1CDK4
SCHEMBL21397076 0.94 CYP11B2 (0.38) CYP11B2KDM4EATML3MBTL1CDK4
SCHEMBL21397099 0.94 CYP11B2 (0.39) CYP11B2KDM4EATML3MBTL1DHODH
SCHEMBL21396832 0.92 CYP11B2 (0.34) CYP11B2KDM4ECDK4CDK6DHODH
SCHEMBL19909124 0.89 KDM4E (0.42) CYP11B2KDM4EATML3MBTL1PDE10A
SCHEMBL19908876 0.89 SQOR (0.40) CYP11B2KDM4EATML3MBTL1PDE10A
SCHEMBL20620125 0.88 CYP11B2 (0.49) CYP11B2KDM4EDHODHPDE10AKMT2A
SCHEMBL21396825 0.88 CYP11B2 (0.38) CYP11B2KDM4EATML3MBTL1DHODH
SCHEMBL15945597 0.88 KDM4E (0.46) KDM4EATML3MBTL1CDK4CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885KDM4E 4364/4885ATM 1817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.